|
2006 ICD-9 codes - 4 of 7 |
|||||||||||||||||||||||||
|
Sclerosing mesenteritis - This is an uncommon mesenteric disease with fewer than 300 cases reported. Patients most frequently report symptoms and signs of abdominal pain, abdominal mass, or symptoms related to bowel obstruction. However, many patients have no symptoms, and the disease is discovered incidentally. Likewise, laboratory tests, including imaging studies, are also considered nonspecific. The definitive diagnosis thus requires a biopsy. The disease may present as a single mass, multiple masses, or as diffuse thickening of the mesentery. The majority of reported cases have involved the small bowel mesentery, sole involvement of the mesocolon has been well documented in approximately 20% of cases. Other rare intra-abdominal sites that have been involved are the mesoappendix, peripancreatic area, omentum, and pelvis. Chronic Renal disease code 585 is replaced by more specific codes with six stages. 585.1 Chronic kidney disease, Stage I First we need to consider, what do kidneys do? The kidneys:
Web links. http://renux.dmed.ed.ac.uk/EdREN/EdRenINFObits/CRFLong.html http://www.kidney.org/professionals/kdoqi/guidelines_ckd/toc.htm http://www.kidney.org/professionals/kdoqi/history.cfm In the last few years a useful classification of renal failure has been developed. It is based on GFR - glomerular filtration rate. This can be measured, or predicted from age, weight, and blood tests etc.
At stages 1-3 kidney disease there are generally minor
symptoms and the patient may not be aware of any problem at all. Stage 2 kidney disease is a tricky area, because normal GFR falls with age, and therefore many normal older people may fall into this category. Equations used to predict GFR (rather than real measurements) may also give falsely low results in people with near-normal function. At stage 4 the patient feels unwell.
Two "unspecified" urinary obstruction codes have been added. 599.60 Urinary obstruction, unspecified |
|||||||||||||||||||||||||
| ICD-9 Test 4 | |||||||||||||||||||||||||